Skip to content

Microdosing: all studies

Page 9 of 56: studies 81 to 90 of 555, newest first. Back to the microdosing overview

Research

Side effects of microdosing lysergic acid diethylamide and psilocybin: A systematic review of potential physiological and psychiatric outcomes

Neuropharmacology March 7, 2025 Stefan Modzelewski, Anna Stankiewicz, Napoleon Waszkiewicz et al. 5 citations

This review is limited by the heterogeneity in reporting side effects and the short duration of many studies. Future studies should transparently and systematically present a description of side effects.

Towards a dynamic processual model of psychedelic microdosing.

International Journal of Drug Policy February 1, 2025 Jason Hughes, Joshua Stuart-Bennett, Michael Dunning et al. 2 citations

Existing research highlights an increase in psychedelic microdosing, particularly for therapeutic purposes and as a means for self-enhancement. However, we know little about the different routes into and out of microdosing, particularly by those who do not consume other illicit substances, and of the processes involved in the development, maintenance, and cessation of practices. Drawing upon a...

Multimodal creativity assessments following acute and sustained microdosing of lysergic acid diethylamide.

Psychopharmacology February 1, 2025 Robin J Murphy, Rachael Sumner, Kate Godfrey et al. 9 citations

Enhanced creativity is often cited as an effect of microdosing (taking repeated low doses of a psychedelic drug). There have been recent efforts to validate the reported effects of microdosing, however creativity remains a difficult construct to quantify. The current study aimed to assess microdosing's effects on creativity using a multimodal battery of tests as part of a randomised controlled...

Notes from the Field: Severe Health Outcomes Linked to Consumption of Mushroom-Based Psychoactive Microdosing Products - Arizona, June-October 2024.

MMWR Morbidity and Mortality Weekly Report January 9, 2025 Heather L. Walker, Maureen Roland, Steven Dudley et al. 1 citation

In June 2024, Arizona Department of Health Services (ADHS) was notified by Arizona's poison control centers (PCCs)* of adverse health outcomes occurring after ingestion of a Diamond Shruumz-brand product containing proprietary blends of mushroom extracts and adaptogens.† These products were sold as chocolate bars, gummies, and cones and could be purchased online or at local retailers...

Effects of fertilizer microdosing on soil phosphorus and sulphur availability to Solanum macrocarpon in Southwest Nigeria

Journal of Agricultural Sciences, Belgrade 2025 Ifeoluwa Oluwaponle, Francis Olatoberu, Mary Idowu et al.

This present study aimed at evaluating the effect of fertilizer rate and time of application on yield, and determined the availability of soil P and S to S. macrocarpon. The experiment was conducted in the derived savanna (Ogbomoso) and the rainforest (Ilesha) in southwest Nigeria. The treatments were arranged in a factorial combination and laid out in a split-plot design with four replicates....

Optimizing yield, nitrogen uptake and nitrogen use efficiency in fluted pumpkin through fertilizer microdosing

Journal of Agricultural Sciences, Belgrade 2025 Francis Olatoberu, Mary Idowu, Durodoluwa Oyedele et al.

Due to severely weathered soils and copious amounts of rainfall, the timing and rate of fertilizer application to enhance yields, nitrogen use efficiency, and recovery of fluted pumpkin (Telfairia occidentalis) have been key concerns in southwestern Nigeria. The experiment was conducted using a 2 x 2 x 5 randomized complete block split plot design (RCBSPD) with four varieties. Ilesa and...

Safety of Indocyanine Green Microdosing for Clinical Imaging of CSF Ventricular Dynamics and Extracranial Outflow.

Journal of neuroimaging : official journal of the American Society of Neuroimaging 2025 Miriam Zamorano, Banghe Zhu, Ahmed T Massoud et al.

Intravenous administration of indocyanine green (ICG) has been approved in brain surgeries for decades, yet concerns about neurotoxicity prevent its direct administration into the cerebrospinal fluid (CSF). Armed with prior animal studies demonstrating the feasibility of using ICG microdosing into the CSF, we sought to evaluate its nonclinical safety profile and obtain surrogate measures in...

DOI: 10.1111/jon.70028 (opens in new tab) Full text (opens in new tab) Brain injury Cervical lymphatics Indocyanine green Near‐infrared fluorescence +2

Potential therapeutic effects of psychedelics in small doses: Is there a role for microdosing in psychiatry?

International review of neurobiology 2025 Iva Totomanova, Eline Haijen, Petra P M Hurks et al.

Clinical trials using full doses of psychedelics have provided preliminary evidence supporting their safety and efficacy in treating a variety of physical and psychological conditions. Anecdotal reports indicate that even very small amounts of these substances may provide therapeutic benefits, though robust clinical studies are still needed. This chapter reviews the current experimental studies...

Mushrooms, Microdosing, and Mental Illness: The Effect of Psilocybin on Neurotransmitters, Neuroinflammation, and Neuroplasticity.

Neuropsychiatric Disease and Treatment 2025 Daniel A Kinderlehrer 13 citations

The incidence of mental health disorders is increasing worldwide. While there are multiple factors contributing to this problem, neuroinflammation underlies a significant subset of psychiatric conditions, particularly major depressive and anxiety disorders. Anti-inflammatory interventions have demonstrated benefit in these conditions. Psilocin, the active ingredient of mushrooms in the...

Microdosing of a kappa opioid receptor agonist within proximal nucleus accumbens shell microstructures revealing opposing behavioral outcomes.

Neuroscience December 17, 2024 Erin B Rousseau, Hannah D Jackson, Suman Guha et al.

Targeted intracranial delivery of molecularly-specific therapies within intricate brain structures poses a formidable challenge due to the heterogeneity of neuronal phenotypes and functions. Here we report the use of an implantable, miniaturized neural drug delivery system permitting dynamic adjustment of pharmacotherapies. Specifically, we exploit the spatial accuracy afforded by this method...

DOI: 10.1016/j.neuroscience.2024.10.047 (opens in new tab) Full text (opens in new tab) Behavior modification Drug delivery Micro-invasive Reward and aversion